Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 164.23M P/E - EPS this Y 11.30% Ern Qtrly Grth -
Income -64.74M Forward P/E -3.91 EPS next Y -28.30% 50D Avg Chg -3.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 2.28 EPS next 5Y - 52W High Chg -31.00%
Recommedations 1.60 Quick Ratio 20.69 Shares Outstanding 34.29M 52W Low Chg 165.00%
Insider Own 1.31% ROA -24.04% Shares Float 24.82M Beta 1.26
Inst Own 118.83% ROE -36.71% Shares Shorted/Prior 4.03M/4.84M Price 7.15
Gross Margin - Profit Margin - Avg. Volume 115,251 Target Price 65.88
Oper. Margin - Earnings Date Oct 31 Volume 42,249 Change -2.72%
About Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Longboard Pharmaceuticals, Inc. News
11/13/24 Longboard commences Phase III trial of bexicaserin for DEEs seizure treatment
11/12/24 Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
11/07/24 Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
10/15/24 Health Care Roundup: Market Talk
10/15/24 Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%
10/15/24 Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn
10/14/24 Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record
10/14/24 Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
10/14/24 Longboard Pharmaceuticals-H. Lundbeck Deal Undervalues Franchise, Truist Says
10/14/24 Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?
10/14/24 Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck
10/14/24 Sector Update: Health Care Stocks Advance Premarket Monday
10/14/24 Denmark's Lundbeck bets on epilepsy drug with $2.6 billion Longboard deal
10/14/24 Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline
10/09/24 Longboard Pharmaceuticals Inc (LBPH) Q2 2024 Earnings Call Highlights: Promising Clinical ...
10/04/24 Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
09/27/24 Longboard Pharmaceuticals begins Phase III Dravet syndrome trial
09/26/24 Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome
09/20/24 Longboard Stock Soars on FDA Designations for Epilepsy Drug
09/19/24 Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome
LBPH Chatroom

User Image biolover Posted - 4 days ago

$MDGL $VKTX Betaville report on $LBPH acquisition was released on Oct1 and the event was fulfilled on Oct 14. 2024

User Image liebe442 Posted - 6 days ago

$LBPH is it glitched or does that say 61.99

User Image themacromindset Posted - 1 week ago

Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs) $LBPH

User Image Whale_Boat_Captain_PhD Posted - 1 week ago

All true, but there is the possibility that Banks inflate the price for political reasons. Check out how $LBPH was propped up for months. Now, that was bought out, but still, things happen. I'm very neutral on this stock, now. I put nothing past big money, though.

User Image DonCorleone77 Posted - 1 week ago

$LBPH Longboard Pharmaceuticals reports Q3 EPS (63c), consensus (58c) At September 30, 2024, Longboard's cash, cash equivalents and short-term investments were approximately $288.4 million.

User Image liebe442 Posted - 2 weeks ago

$LBPH almost to 60

User Image Mergerbrief Posted - 2 weeks ago

$LBPH / $HLUNB - HSR Expires Today MergerBrief.com Sign Up For Full Schedule

User Image DonCorleone77 Posted - 2 weeks ago

$LBPH Longboard Pharmaceuticals granted Orphan Drug Designation for bexicaserin Longboard Pharmaceuticals announced that the U.S. Food and Drug Administration has granted orphan drug designation to bexicaserin in the treatment of Lennox-Gastaut Syndrome.

User Image Realcrillo Posted - 2 weeks ago

@Bullbear1010101 $LBPH rally sparked this rally as they have a similar drug. this hasnt crashed because Point72, Perceptive Advisors took stakes. may not be a scam

User Image DonCorleone77 Posted - 10/31/24

$LBPH Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings Pre-earnings options volume in Longboard Pharmaceuticals Inc is normal with calls leading puts 5:2. Implied volatility suggests the market is anticipating a move near 0.8%, or 45c, after results are released. Median move over the past eight quarters is 4.3%.

User Image Sonics2563 Posted - 10/29/24

$TARS and they got $lbph right

User Image Mergerbrief Posted - 10/28/24

$LBPH / $HLUNB - HSR File By Date MergerBrief.com Sign Up For Full Schedule

User Image JimmyRussels420 Posted - 10/26/24

$CYBN sharing some thoughts with a friend…could be something here $DRUG $LBPH

User Image GildedAge01 Posted - 10/26/24

$LBPH when will deal be secured ?

User Image cubie Posted - 10/23/24

$LBPH $VKTX $ALT $IOVA @JohnnyTest24 @judgeyoung2 is after election yet? that's all

User Image liebe442 Posted - 10/23/24

$LBPH

User Image sjl03 Posted - 10/23/24

$AIFF $CYBN $DRUG $JNJ $LBPH

User Image Amraa2 Posted - 10/22/24

$LBPH so earning we go to 63+++ or

User Image Burningsmoke Posted - 10/22/24

$DRUG $JNJ $LBPH $CYBN $AIFF https://financefeeds.com/drug-5900-weekly-surge-turns-attention-cybin-cybn-rallying-23-this-week-in-anticipation-for-major-milestones/

User Image refrank Posted - 10/22/24

$LBPH is this a good deal? Will we see upward price movement??

User Image perchedcats Posted - 10/22/24

@BullsVSBearsVSYoMomma gaps in $LBPH never filled… just saying

User Image Valuecat Posted - 4 weeks ago

$LCTX shoulda bought Longboard $LBPH instead

User Image Alt_Fuel Posted - 1 month ago

@Huskerg @LonoTrader @sweddle Everyone is looking for another $DRUG kinda stock but you need to pay attention why $DRUG moved roughly 2900% in just a matter of days. This is what I looked for 1) Right after $LBPH buyout, another company targeting the same drug mechanism 2) Float 3) Cash 4) Market valuation vs $LVPH 5) Current development stage And Boom 💥 $DRUG worked huge in my favor 12:16 PM · Oct 18, 2024 · 11.8K Views https://x.com/Pharmdca/status/1847310828074336448

User Image insiderbuyingselling Posted - 1 month ago

$LBPH new insider selling: 16667 shares. http://insiderbuyingselling.com/?t=LBPH

User Image TheBlaze Posted - 1 month ago

$ZVRA $LBPH with Arimoclomol (MIPLYFFA) approved and the drug a slam dunk cash cow why not add ZVRA to the list of potential acquisitions by end of year? At least 100% premium from here.

User Image kylevallans Posted - 1 month ago

$DRUG - The company is currently developing its lead product candidate, BMB-101, a 5-HT2C receptor agonist (designed to activate serotonin receptors in the brain, influencing various neurological and psychiatric conditions). This is similar to $LBPH (lead drug LP352), which was acquired at a significant premium yesterday, fueling the DRUG run.

User Image TheBlaze Posted - 1 month ago

$ZVRA $LBPH and $DRUG are both having a monster week! If you Longboarders want to catch another big wave come ride the Zevra zebra into a double coming soon here. With acquisition season heating up I’m betting we see $ZVRA acquired in the coming months for at least a 100% premium over today’s price.

User Image SetNForget777 Posted - 1 month ago

$LBPH Closed at 58.90

User Image jackofalltrade Posted - 1 month ago

@Walter100 that is what happened with $LBPH Price targets kept getting raised. I bought in 2022. I was in $ARNA originally so I saw it from spin-off to buy out. I actually used some of my gains for ARNA for LBPH. Looking back I wish I had bought more but decided to be conservative. I’m not getting any younger.

User Image Walter100 Posted - 1 month ago

What Apr says hrre about $LPTX price targets getting revised upwards by analysts from currentl average of around $11, as and when catalysts hit in the next ~ 12 months is exactly what seems to have happened with $LBPH - nice leg ups in price, 10x in the last 12 months if I'm right : (continued in reply post)

Analyst Ratings
HC Wainwright & Co. Buy Sep 18, 24
Wedbush Outperform Sep 17, 24
Cantor Fitzgerald Overweight Sep 16, 24
Truist Securities Buy Sep 10, 24
Evercore ISI Group Outperform Aug 26, 24
HC Wainwright & Co. Buy Aug 22, 24
B. Riley Securities Buy Aug 5, 24
Citigroup Buy Aug 2, 24
Cantor Fitzgerald Overweight Aug 2, 24